Zobrazeno 1 - 2
of 2
pro vyhledávání: '"L. S. Danielson"'
Autor:
J. Guan, E. R. Tucker, H. Wan, D. Chand, L. S. Danielson, K. Ruuth, A. El Wakil, B. Witek, Y. Jamin, G. Umapathy, S. P. Robinson, T. W. Johnson, T. Smeal, T. Martinsson, L. Chesler, R. H. Palmer, B. Hallberg
Publikováno v:
Disease Models & Mechanisms, Vol 9, Iss 9, Pp 941-952 (2016)
The first-in-class inhibitor of ALK, c-MET and ROS1, crizotinib (Xalkori), has shown remarkable clinical efficacy in treatment of ALK-positive non-small cell lung cancer. However, in neuroblastoma, activating mutations in the ALK kinase domain are ty
Externí odkaz:
https://doaj.org/article/0874c752cd854424a6b9a3ca42147e8d
Autor:
G, Carreno, J K R, Boult, J, Apps, J M, Gonzalez-Meljem, S, Haston, R, Guiho, C, Stache, L S, Danielson, A, Koers, L M, Smith, A, Virasami, L, Panousopoulos, M, Buchfelder, T S, Jacques, L, Chesler, S P, Robinson, J P, Martinez-Barbera
Publikováno v:
Endocrine-Related Cancer
Pharmacological inhibition of the sonic hedgehog (SHH) pathway can be beneficial against certain cancers but detrimental in others. Adamantinomatous craniopharyngioma (ACP) is a relevant pituitary tumour, affecting children and adults, that is associ